"Bliib Fit - Mach Mit!" in Alters- Und Pflegeinstitutionen
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Physical Fitness in Older Adults
- Sponsor
- Eastern Switzerland University of Applied Sciences
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- Short Physical Performance Battery (SPPB)
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
The goal of this clinical trial is to learn, if the video-based exercise program "Bliib fit - mach mit!" can be used to improve physical fitness in older adults living in residential care facilities. The main questions it aims to answer are:
Does the video-based exercise program improve participants' physical fitness? Does the video-based exercise program improve participants' quality of life, perceived fall risk, self-efficacy and daily physical activity levels?
Researchers will compare this exercise program to an optimized standard care activation program (caregiver-led) to see if the video-based program can affect physical fitness in older adults living in residential care facilities.
Participants will participate in the exercise or activation program for 12 weeks, four times a week, with each session lasting 20 minutes.
Investigators
Eling de Bruin
Prof.
Eastern Switzerland University of Applied Sciences
Eligibility Criteria
Inclusion Criteria
- •Written informed consent
- •Low to moderate risk of falling
- •Physically and cognitively able to independently carry out exercise instructions (based on referral of clinical staff on site)
- •Mini Mental State Examination (MMSE) test score ≥ 20
Exclusion Criteria
- •Inability to speak or understand German
- •High risk of falling
- •Unstable cardiovascular condition or other health condition, which does not support a safe participation in exercise program (based on referral of clinical staff on site, patient file)
- •Scheduled transfer to another institution within the next 3 months
Outcomes
Primary Outcomes
Short Physical Performance Battery (SPPB)
Time Frame: Baseline, end of intervention at 12 weeks, long-term follow-up 12 weeks after intervention ends
Lower extremity function and mobility is assessed using the Short Physical Performance Battery (SPPB) (standing balance, gait speed, lower extremity strength). The SPPB is an objective and valid measurement instrument to assess lower extremity function and mobility (\> 65 years of age). The measurement instrument consists of three physical tasks: walking, chair-rise-test (sit-to-stand) and standing balance.
Grip strength
Time Frame: Baseline, end of intervention at 12 weeks, long-term follow-up 12 weeks after intervention ends
Upper extremity strength is assessed using the grip strength test (hand dynamometer). It is a relevant and valid assessment in older adults to assess muscle strength and overall physical function. Participants squeeze a hand dynamometer as hard as they can, three times with each hand.
2-Minutes Walking Test
Time Frame: Baseline, end of intervention at 12 weeks, long-term follow-up 12 weeks after intervention ends
Aerobic endurance is assessed via the 2-Minutes Walking test. The 2MWT is a submaximal exercise test to assess overall physical fitness and endurance in research and clinical practice. The distance covered in two minutes is recorded. Reference values for adults are available to determine presence of impairments in walking ability, functional endurance, and overall functional status. Oxygen saturation (SpO2) and heart rate (HR) are measured before and after the test using a pulse oximeter. Furthermore, dyspnea and the effort in both legs are measured before and after the test using the Borg scale.
Secondary Outcomes
- Health-related quality of life(Baseline, end of intervention at 12 weeks, long-term follow-up 12 weeks after intervention ends)
- Falls Efficacy Scale(Baseline, end of intervention at 12 weeks, long-term follow-up 12 weeks after intervention ends)
- Self-Efficacy(Baseline, end of intervention at 12 weeks, long-term follow-up 12 weeks after intervention ends)
- Accelerometery(Baseline, end of intervention at 12 weeks, long-term follow-up 12 weeks after intervention ends)